These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 19739035)

  • 1. The metabolic syndrome as a risk factor for venous and arterial thrombosis.
    Dentali F; Squizzato A; Ageno W
    Semin Thromb Hemost; 2009 Jul; 35(5):451-7. PubMed ID: 19739035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic syndrome and the risk of arterial and venous thrombosis.
    Franchini M; Targher G; Montagnana M; Lippi G
    Thromb Res; 2008; 122(6):727-35. PubMed ID: 17996282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
    Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome, diabetes and cardiovascular events: current controversies and recommendations.
    Zarich SW
    Minerva Cardioangiol; 2006 Apr; 54(2):195-214. PubMed ID: 16778752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM; Guay A; Feeley R; Saad F
    J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercoagulability in the metabolic syndrome.
    Nieuwdorp M; Stroes ES; Meijers JC; Büller H
    Curr Opin Pharmacol; 2005 Apr; 5(2):155-9. PubMed ID: 15780824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common risk factors for both arterial and venous thrombosis.
    Lowe GD
    Br J Haematol; 2008 Mar; 140(5):488-95. PubMed ID: 18275426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding of multiple risk factors as the metabolic syndrome: distillation or deconstruction.
    Boden-Albala B
    Semin Neurol; 2006 Feb; 26(1):108-16. PubMed ID: 16479449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostasis alterations in metabolic syndrome (review).
    Palomo I; Alarcón M; Moore-Carrasco R; Argilés JM
    Int J Mol Med; 2006 Nov; 18(5):969-74. PubMed ID: 17016629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of metabolic profile in a clinical setting.
    Pervanidou P; Kanaka-Gantenbein C; Chrousos GP
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):589-95. PubMed ID: 16912555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic risk factors: basic pathophysiology.
    Martinelli I; Bucciarelli P; Mannucci PM
    Crit Care Med; 2010 Feb; 38(2 Suppl):S3-9. PubMed ID: 20083911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive dysfunction associated with metabolic syndrome.
    Taylor VH; MacQueen GM
    Obes Rev; 2007 Sep; 8(5):409-18. PubMed ID: 17716298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of arterial stiffness and endothelial dysfunction with metabolic syndrome in obese children.
    Mimoun E; Aggoun Y; Pousset M; Dubern B; Bouglé D; Girardet JP; Basdevant A; Bonnet D; Tounian P
    J Pediatr; 2008 Jul; 153(1):65-70. PubMed ID: 18571538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome: at the crossroads of cardiorenal risk.
    Natali A; Pucci G; Boldrini B; Schillaci G
    J Nephrol; 2009; 22(1):29-38. PubMed ID: 19229816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and thrombosis.
    Darvall KA; Sam RC; Silverman SH; Bradbury AW; Adam DJ
    Eur J Vasc Endovasc Surg; 2007 Feb; 33(2):223-33. PubMed ID: 17185009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome, haemostasis and thrombosis.
    Alessi MC; Juhan-Vague I
    Thromb Haemost; 2008 Jun; 99(6):995-1000. PubMed ID: 18521499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of monocyte chemoattractant protein-1 -2518 polymorphism with metabolic syndrome in a South Indian cohort.
    Kaur S; Panicker SR; James T; Sarma PS; Thankappan KR; Kartha CC
    Metab Syndr Relat Disord; 2009 Jun; 7(3):193-8. PubMed ID: 19450143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
    Brunero S; Lamont S; Fairbrother G
    Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and cognitive disorders: is the sum greater than its parts?
    Yaffe K
    Alzheimer Dis Assoc Disord; 2007; 21(2):167-71. PubMed ID: 17545744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.